Tele-Prescribing in the Crosshairs: Navigating the Latest Regulatory Activity Coming From the DEA, HHS, and Other Agencies Governing Tele-Prescriptions of Controlled Substances

On November 16, 2023, Libby Baney will present at the American Conference Institute’s Advanced Forum on Telehealth. In her session, “Tele-Prescribing in the Crosshairs: Navigating the Latest Regulatory Activity Coming From the DEA, HHS, and Other Agencies Governing Tele-Prescriptions of Controlled Substances,” Libby and her fellow panelists will:

• Examine the evolution of the Ryan Haight Act since 2008
• Tackle the uncertainty of looming rule changes by the DEA & SAMHSA to the prescription of controlled substances via telemedicine
• Address how telehealth providers can operationalize new regulatory changes coming down the pike without sacrificing efficiency, business growth and their bottom line
• Provide critical takeaways for efficient and compliant Telepharmacy implementation efforts
• Take a look at concrete real-life scenarios where tele-prescribing practices have come under agency scrutiny
• Share what telehealth companies need to know about the FDA’s new proposed rule on Nonprescription Drug Products with an Additional Condition for Nonprescription Use